Inventor · disambiguated record
Todd Eliot Golde
Also filed as: GOLDE TODD E · GOLDE TODD ELIOT
8 granted patents·16 pending applications·59 citations·filing 2001–2024
82Inventor score
Top patents by PatentIndex Score
24 records- 0188US6911466B2Aβ42 lowering agentsUNIV CALIFORNIA·Filed 2001·Granted Jun 28, 2005·50 cites·30 claims
- 0277US10030067B2Compounds for treating neurodegenerative proteinopathiesUNIV FLORIDA·Filed 2014·Granted Jul 24, 2018·5 cites·11 claims
- 0368US7097998B2Aβ42 lowering agentsMAYO FOUNDATION·Filed 2004·Granted Aug 29, 2006·4 cites·22 claims
- 0466US2025179168A1Materials and methods for treating stress-related disorders and cancerUNIV FLORIDA·Filed 2024·Application pending·0 cites
- 0560US12258395B2Materials and methods for treating stress-related disorders and cancerUNIV FLORIDA·Filed 2019·Granted Mar 25, 2025·0 cites·8 claims
- 0658US2010298202A1Bri polypeptides and reducing ab aggregationMAYO FOUNDATION·Filed 2008·Application pending·0 cites
- 0757US2007253905A1Abeta42 LOWERING AGENTSMAYO FOUNDATION·Filed 2007·Application pending·0 cites
- 0857US2007253906A1Abeta42 LOWERING AGENTSMAYO FOUNDATION·Filed 2007·Application pending·0 cites
- 0956US11345738B2Compounds for treating neurodegenerative proteinopathiesUNIV FLORIDA·Filed 2018·Granted May 31, 2022·0 cites·16 claims
- 1054US2010143365A1Methods and materials related to anti-amyloid antibodiesMAYO FOUNDATION·Filed 2009·Application pending·0 cites
- 1151US11434281B2Monoclonal antibodies targeting PHF1 and AT8 epitopes of human tau proteinUNIV FLORIDA·Filed 2020·Granted Sep 6, 2022·0 cites·16 claims
- 1251US2005186559A1Abeta42 lowering agentsUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 1347US11629183B2Monoclonal antibodies targeting microtubule-binding domain of tau protein and methods of detecting tau protein in vivoUNIV FLORIDA·Filed 2018·Granted Apr 18, 2023·0 cites·10 claims
- 1447US2024148868A1Chimeric phagocytic receptors for treatment of neurodegenerative disordersUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 1545US2006004086A1Method of reducing Abeta42 and treating diseasesUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 1645US2022307055A1Improved production of recombinant aav using embryonated avian eggsUNIV FLORIDA·Filed 2020·Application pending·0 cites
- 1743US7786283B2BRI constructs and methods of usingMAYO FOUNDATION·Filed 2002·Granted Aug 31, 2010·0 cites·25 claims
- 1841US2022324943A1Multimeric protein domains for multifunctionality and enhanced secretion of therapeutic proteinsUNIV FLORIDA·Filed 2020·Application pending·0 cites
- 1940US2008021085A1Method of reducing abeta42 and treating diseasesMAYO FOUNDATION·Filed 2007·Application pending·0 cites
- 2039US2009175894A1Methods and materials for producing a generic anti-amyloid immune response in mammalsGOLDE TODD E·Filed 2006·Application pending·0 cites
- 2139US2010104577A1Methods and materials related to anti-a (beta) antibodiesGOLDE TODD E·Filed 2007·Application pending·0 cites
- 2236US2011206670A1Methods and materials related to anti-amyloid antibodiesGOLDE TODD E·Filed 2011·Application pending·0 cites
- 2334US2011262387A1Methods and materials for reducing or suppressing amyloid depositionDAS PRITAM·Filed 2011·Application pending·0 cites
- 2433US2011021471A1REDUCING Abeta42 LEVELS AND Abeta AGGREGATIONGOLDE TODD E·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →